Identification of the apical membrane-targeting signal of the multidrug resistance-associated protein 2 (MRP2/cMOAT)

被引:50
作者
Harris, MJ
Kuwano, M
Webb, M
Board, PG [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Med, Mol Genet Grp, Canberra, ACT 0200, Australia
[2] Kyushu Univ, Grad Sch Med Sci, Dept Biochem Med, Fukuoka 8128582, Japan
[3] Australian Natl Univ, Biotron Ltd, Canberra, ACT 0200, Australia
关键词
D O I
10.1074/jbc.M010566200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human canalicular multispecific organic anion transporter (cMOAT), known as the multidrug resistance-associated protein 2 (MRP2), is normally expressed in the liver and to a lesser extent in the kidney proximal tubules. In these tissues MRP2 specifically localizes to the apical membrane. The construction of MRP2 fused to the green fluorescent protein, and subsequent site-directed mutagenesis enabled the identification of a targeting signal in MRP2 that is responsible for its apical localization in polarized cells. The specific apical localization of MRP2 is due to a C-terminal tail that is not present in the basolaterally targeted MRP1. Deletion of three amino acids from the C-terminal of MRP2 (Delta MRP2) causes the protein to be localized predominantly in the basolateral membrane in polarized Madin-Darby canine kidney cells. Interestingly, MRP2 expressed in a mouse leukemia cell line (L1210 cells) predominantly accumulates intracellularly with minimal cell membrane localization. In contrast, Delta MRP2 was shown to predominantly localize in the cell membrane in L1210 cells. Increased transport of 2,4-dinitrophenyl glutathione from L1210 cells expressing Delta MRP2 showed that the re-targeted protein retains its normal function.
引用
收藏
页码:20876 / 20881
页数:6
相关论文
共 29 条
[1]   ICM - A NEW METHOD FOR PROTEIN MODELING AND DESIGN - APPLICATIONS TO DOCKING AND STRUCTURE PREDICTION FROM THE DISTORTED NATIVE CONFORMATION [J].
ABAGYAN, R ;
TOTROV, M ;
KUZNETSOV, D .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1994, 15 (05) :488-506
[2]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[3]  
Buchler M, 1996, J BIOL CHEM, V271, P15091
[4]   Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter [J].
Chen, ZS ;
Kawabe, T ;
Ono, M ;
Aoki, S ;
Sumizawa, T ;
Furukawa, T ;
Uchiumi, T ;
Wada, M ;
Kuwano, M ;
Akiyama, S .
MOLECULAR PHARMACOLOGY, 1999, 56 (06) :1219-1228
[5]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[6]  
Cui YH, 1999, MOL PHARMACOL, V55, P929
[7]   Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells [J].
Evers, R ;
Zaman, GJR ;
vanDeemter, L ;
Jansen, H ;
Calafat, J ;
Oomen, LCJM ;
Elferink, RPJO ;
Borst, P ;
Schinkel, AH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (05) :1211-1218
[8]   Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA [J].
Evers, R ;
Kool, M ;
van Deemter, L ;
Janssen, H ;
Calafat, J ;
Oomen, LCJM ;
Paulusma, CC ;
Elferink, RPJO ;
Baas, F ;
Schinkel, AH ;
Borsi, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) :1310-1319
[9]   Protein modules as organizers of membrane structure [J].
Fanning, AS ;
Anderson, JM .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (04) :432-439
[10]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723